ID: 701
Titel: HER2CLIMB-02
Provsamlingsansvarig: Barbro Linderholm
Start insamling: -
Slut insamling: -
Beskrivning: Randomized, double-blind, phase 3 study of tucatinib or placebo in combination with ado-trastuzumab emtansine (T-DM1) for subjects with unresectable locally-advanced or metastatic HER2+ breast cancer

PROVTYP;PROVGIVARE
Blood(for biomarker analyses);5
Tumour tissue sample;5